Bladder Cancer - Results from #280

REVIEW UroToday

Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients. June 28, 2024

Assessing risk of lymph node invasion in complete responders to neoadjuvant chemotherapy for muscle-invasive bladder cancer. June 28, 2024

Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data Study. June 28, 2024

Atypical B cells promote cancer progression and poor response to Bacillus Calmette-Guérin in non-muscle invasive bladder cancer. June 27, 2024

Robotic Radical Cystectomy of the Bladder June 27, 2024

Performance of the URO17® Test in Detecting Bladder Cancer - Expert Commentary June 26, 2024

Evaluation of URO17® to improve non-invasive detection of bladder cancer June 26, 2024

Sequential Intravesical Chemotherapy for Treatment Naïve, High-Risk Non-Muscle Invasive Bladder Cancer: Oncologic Outcomes, Tolerance, and Comparison to Contemporary Controls. June 26, 2024

Frontline immune checkpoint inhibitors in patients ≥ 90 years with advanced urothelial cancer: a single center experience. June 26, 2024

Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors. June 26, 2024

A Safety Net for Safety Net Hospitals: Affiliation with Cancer Centers and Survival Outcomes in Patients with Metastatic Genitourinary Cancers June 25, 2024

Imfinzi Demonstrated Statistically Significant and Clinically Meaningful Improvement in Event-Free Survival and Overall Survival for Muscle-Invasive Bladder Cancer in NIAGARA Phase III Trial June 25, 2024

Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels. June 25, 2024

Clinical upstaging after neoadjuvant chemotherapy impacting eligibility for vaginal-sparing cystectomy: identifying bladder cancer patients who may benefit from interim imaging. June 25, 2024

Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer Patients. June 24, 2024

The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. June 24, 2024

Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration. June 24, 2024

Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and Meta-analysis. June 21, 2024

CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease course. June 21, 2024

Teaching hospitals and textbook outcomes after major urologic cancer surgery. June 21, 2024

Page 15 of 517